SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.

[1]  M. Larsen,et al.  Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. , 2014, Journal of proteomics.

[2]  T. Yamashita,et al.  High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma , 2013, PloS one.

[3]  Y. Murakumo,et al.  Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression , 2010, Pathology international.

[4]  Brett Larsen,et al.  Label-free quantitative proteomics trends for protein-protein interactions. , 2013, Journal of proteomics.

[5]  Claude Négrier,et al.  Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. , 2013, Critical reviews in oncology/hematology.

[6]  J. Shao,et al.  Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis , 2012, Journal of Translational Medicine.

[7]  Francesca Pentimalli,et al.  Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery. , 2013, Mass spectrometry reviews.

[8]  M. Wilkerson,et al.  Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. , 2010, Cancer cell.

[9]  Lei Liu,et al.  Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion , 2010, BMC Cancer.

[10]  Trong Khoa Pham,et al.  Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). , 2007, Journal of proteome research.

[11]  Jingchu Luo,et al.  Secreted protein prediction system combining CJ-SPHMM, TMHMM, and PSORT , 2003, Mammalian Genome.

[12]  N. Zolotarjova,et al.  Multi-component immunoaffinity subtraction and reversed-phase chromatography of human serum. , 2008, Methods in molecular biology.

[13]  T. Lim,et al.  iTRAQ Based Quantitative Proteomics Approach Validated the Role of Calcyclin Binding Protein (CacyBP) in Promoting Colorectal Cancer Metastasis* , 2013, Molecular & Cellular Proteomics.

[14]  F. Esteva,et al.  Serum CD44 levels and overall survival in patients with HER2-positive breast cancer , 2011, Breast Cancer Research and Treatment.

[15]  Deepa Naishadham,et al.  Cancer statistics for Hispanics/Latinos, 2012 , 2012, CA: a cancer journal for clinicians.

[16]  Sean L Seymour,et al.  The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.

[17]  T. Ørntoft,et al.  Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors , 2014, Proteomics.

[18]  Mårten Fernö,et al.  Grading Breast Cancer Tissues Using Molecular Portraits* , 2013, Molecular & Cellular Proteomics.

[19]  A. Dirksen,et al.  Preoperative staging of lung cancer with combined PET-CT. , 2009, The New England journal of medicine.

[20]  K. Rabe,et al.  Management of non-small-cell lung cancer: recent developments , 2013, The Lancet.

[21]  S. Brunak,et al.  SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.

[22]  Masahide Takahashi,et al.  CD109 expression levels in malignant melanoma. , 2010, Journal of dermatological science.

[23]  Kelvin H Lee,et al.  Shotgun proteomics using the iTRAQ isobaric tags. , 2006, Briefings in functional genomics & proteomics.

[24]  Wei Li,et al.  Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics. , 2013, Journal of proteomics.

[25]  Ludovic C. Gillet,et al.  Quantitative measurements of N‐linked glycoproteins in human plasma by SWATH‐MS , 2013, Proteomics.

[26]  Ming Yao,et al.  Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer , 2013, PloS one.

[27]  Derek C. Radisky,et al.  Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109 , 2010, Breast Cancer Research and Treatment.

[28]  Paul Dowling,et al.  Analysis of acute‐phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer , 2012, International journal of cancer.

[29]  F. Bertoni,et al.  Syndecan-4 and fibronectin in osteosarcoma , 2012, Pathology.

[30]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[31]  Maria P. Pavlou,et al.  Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology , 2010, Molecular oncology.

[32]  S. Hanash,et al.  In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding. , 2009, Cancer research.

[33]  M. Laakso,et al.  An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis. , 2012, Journal of proteomics.

[34]  Y. Khew-Goodall,et al.  The secretome in cancer progression. , 2013, Biochimica et biophysica acta.

[35]  C. Bowler,et al.  iTRAQ-based proteomic analysis of the metabolism mechanism associated with silicon response in the marine diatom Thalassiosira pseudonana. , 2014, Journal of proteome research.

[36]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[37]  Ioanna Kougioumtzi,et al.  Lung cancer surgery: an up to date. , 2013, Journal of thoracic disease.

[38]  C. Pilarsky,et al.  Laminin, gamma 2 (LAMC2): A Promising New Putative Pancreatic Cancer Biomarker Identified by Proteomic Analysis of Pancreatic Adenocarcinoma Tissues* , 2013, Molecular & Cellular Proteomics.

[39]  Dominique Trudel,et al.  Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer , 2012, The Journal of Biological Chemistry.

[40]  T. Veenstra,et al.  Brugia malayi Excreted/Secreted Proteins at the Host/Parasite Interface: Stage- and Gender-Specific Proteomic Profiling , 2009, PLoS neglected tropical diseases.

[41]  Xianghuo He,et al.  Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC. , 2013, Journal of proteome research.

[42]  Swarnlata Saraf,et al.  Matrix metalloproteinase enzymes and their naturally derived inhibitors: Novel targets in photocarcinoma therapy , 2014, Ageing Research Reviews.

[43]  B. Mroczko,et al.  Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer , 2010, Clinical and Experimental Medicine.

[44]  Jie Zhang,et al.  Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis , 2012, BMC Cancer.

[45]  B. Liu,et al.  Evaluation of three high abundance protein depletion kits for umbilical cord serum proteomics , 2011, Proteome Science.

[46]  Ruedi Aebersold,et al.  A Serum Protein Profile Predictive of the Resistance to Neoadjuvant Chemotherapy in Advanced Breast Cancers* , 2011, Molecular & Cellular Proteomics.

[47]  S. Fulda,et al.  G‐Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1 , 2013, The Journal of pathology.

[48]  Richard J. Simpson,et al.  ExoCarta as a resource for exosomal research , 2012, Journal of extracellular vesicles.

[49]  Jason U Tilan,et al.  Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. , 2011, The American journal of pathology.

[50]  S. Dao,et al.  Automated Mass Spectrometry–Based Functional Assay for the Routine Analysis of the Secretome , 2013, Journal of laboratory automation.

[51]  D. Caccia,et al.  Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways. , 2011, Journal of proteome research.

[52]  M. Salama,et al.  Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer. , 2013, Endocrine-related cancer.

[53]  Q. Hamid,et al.  Differential Roles of CXCL2 and CXCL3 and Their Receptors in Regulating Normal and Asthmatic Airway Smooth Muscle Cell Migration , 2013, The Journal of Immunology.

[54]  R. Götz,et al.  Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-driven murine lung cancer. , 2007, Cancer cell.

[55]  Ludovic C. Gillet,et al.  Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system , 2013, Nature Methods.

[56]  B. Boyes,et al.  Optimization of data-dependent acquisition parameters for coupling high-speed separations with LC-MS/MS for protein identifications. , 2013, Journal of biomolecular techniques : JBT.

[57]  A. Vlahou,et al.  Secretome proteomics for discovery of cancer biomarkers. , 2010, Journal of proteomics.

[58]  Tony Pawson,et al.  Mapping differential interactomes by affinity purification coupled with data independent mass spectrometry acquisition , 2013, Nature Methods.

[59]  M. Ichihara,et al.  Detection of a Soluble Form of CD109 in Serum of CD109 Transgenic and Tumor Xenografted Mice , 2014, PloS one.

[60]  C. Bucana,et al.  Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.